Clinical Trial Update: Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of Olmesartan in paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Atrial Fibrillation Network | Conditions: Heart Disease, Arrhythmia | Phase 3 | Status: COMPLETED